Medicus Pharma Ltd.
Raza Bokhari is an accomplished executive in the medical laboratory and healthcare sectors, currently serving as the Executive Chairman and CEO of Medicus Pharma Ltd. since September 2023. As the Managing Partner of RBx Capital, LP since March 2012, Raza is dedicated to investing in the U.S. Medical Laboratory testing market, with a focus on pharmacogenomics and personalized medicine, aiming to raise $200 million. Previously, Raza held significant leadership positions including Chairman of the Board at Parkway Clinical Laboratories (2014-2024), Executive Chairman and CEO at FSD Pharma Inc. (2018-2021), and Chief Development Officer at Rosetta Genomics (2008-2009). With a robust track record of transforming financially distressed companies and driving operational efficiencies, Raza Bokhari's background is further supported by an MBA from Fox School of Business and an MD from University of Punjab Rawalpindi Medical College.
This person is not in any teams
This person is not in any offices
Medicus Pharma Ltd.
Medicus Pharma Ltd. (TSXV:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Through our diverse experience and extensive industry network, we are building Medicus into a leading pharmaceutical company, committed to deliver better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, we identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization. We look into opportunities where an unmet need exists for improved patient safety and efficacy. Medicus is opportunisticly exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships. Our portfolio of companies include Skinject, Inc.